ClinicalTrials.Veeva

Menu

Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult ED

Vanderbilt University logo

Vanderbilt University

Status

Terminated

Conditions

Nausea

Treatments

Drug: Normal Saline
Drug: Promethazine
Drug: Metoclopramide
Drug: Ondansetron

Study type

Interventional

Funder types

Other

Identifiers

NCT00655642
VUMC 0612369

Details and patient eligibility

About

The purpose of this study is to compare the effectiveness of ondansetron, metoclopramide, and promethazine for the treatment of nausea in the adult emergency department population.

We hypothesize that a single intravenous dose of ondansetron is more effective in reducing nausea than a single IV dose of metoclopramide, promethazine or normal saline placebo in undifferentiated adult emergency department patients.

Enrollment

171 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients age 18 or older who present to the ED with a complaint requiring antiemetic treatment who do not meet the exclusion criteria.

Exclusion criteria

  • Patients less than 18 years of age
  • Unstable patients with SBP < 90
  • Patients with a stated or documented allergy to any of the study medications
  • Patients whose nausea rating if < 40 on the pretreatment VAS scale
  • Patients who have received a commonly accepted antiemetic within the previous 24 hours
  • Patients unwilling or unable to complete the assessment tool before and 30 minutes after study drug dosing

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Quadruple Blind

171 participants in 4 patient groups, including a placebo group

Ondansetron
Active Comparator group
Description:
Ondansetron 4 mg intravenous administration
Treatment:
Drug: Ondansetron
Metoclopramide
Active Comparator group
Description:
Metoclopramide 10 mg intravenous administration
Treatment:
Drug: Metoclopramide
Promethazine
Active Comparator group
Description:
Promethazine 10 mg intravenous administration
Treatment:
Drug: Promethazine
Saline Placebo
Placebo Comparator group
Description:
Volume-matched saline placebo
Treatment:
Drug: Normal Saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems